Habitually, DCs for tumor vaccines are generated from autologous monocytes (moDCs) in the presence of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). The gene discussed is CSF2; the disease is neoplasm.